重大事项：
中通快递-W(02057)拟发售15亿美元的可换股优先票据
复星国际(00656)附属复星商发拟以1.05亿元认购商盟科技新增注册资本，对应取得商盟科技增资后51.0879%的股权
上海医药(02607)：常州制药厂的西格列汀二甲双胍缓释片获得批准生产
中船防务(00317)控股子公司签订16 艘支线集装箱船建造合同
翰思艾泰-B(03378)：HX111完成首例病人用药
经营业绩：
中通快递-W(02057)预计2025年收入总额485亿元至500亿元 同比增长约9.5%至12.9%
信达生物(01801)2025年实现总产品收入约119亿元 同比保持约45%的强劲增长态势
百胜中国(09987)2025年经营利润同比增长11%至13亿美元
华润建材科技(01313)发盈喜 预期2025年度股东应占盈利同比上升大约115%至135%
理文造纸(02314)发盈喜 预期2025年盈利约18.8亿港元至20.0亿港元 同比增长38%至47%
小马智行-W(02026)发盈喜 预期2025年净亏损约6900万美元至8600万美元 同比收窄
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.